CASE CCC IN THE NEWS
Researchers Discover Promising Prognostic Marker for Aggressive Breast Cancer
Case CCC News - Jan 23, 2013
A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spread of breast cancer. Published in Scientific Translational Medicine, the study lays the early foundation for predicting which breast cancer patients may develop more aggressive disease and for designing more effective treatments.
First Harrington Distinguished Scholar Brings Breast Cancer Research to Cleveland
Plain Dealer-Jan 24, 2013
A native of California, Dr. Goutham Narla moved East after graduating from Santa Clara University. He would spend the next 15 years in New York City...An added bonus: Narla's wife, Analisa DiFeo, is furthering her ovarian cancer research at her own lab at Case Comprehensive Cancer Center, which she joined last spring.
Collaboration in academia designed to increase return on research investments
Helio/HemOnc Today - Jan 25, 2013
Point by Brian J. Bolwell, MD, FACP...Private-public partnerships are a very good option. There are certain realities that exist in 2013. The first is that overall reimbursement in health care is declining and will continue to do so...
Cleveland Clinic Opens Wig and Cap Boutique for its Cancer Patients
Plain Dealer - Jan 23, 2013
Barrat-Gordon and Lindecke credit Dr. Brian Bolwell, Taussig chairman since summer 2011 (he was interim chairman prior to that), with creating the atmosphere that makes the new boutique possible.
Highlights From the 2013 Gastrointestinal Symposium, with Neal Meropol, MD
In this podcast, we review some of the news announced at the 2013 Gastrointestinal Cancer Symposium, co-sponsored by ASCO.
Drug Is Shown to Help Pancreatic Cancer Cases
New York Times - Jan 22, 2013
"The simplicity of Abraxane plus gemcitabine may be attractive to physicians and patients," said Dr. Neal J. Meropol, chief of hematology and oncology at University Hospitals and Case Western Reserve University in Cleveland...
Miltenyi Biotec to Contribute Portion of Purchases to Support TRCCC Conference
- 10% off gentleMACS™ or gentleMACS™ Octo Dissociators
- Plus FREE MACS® Tumor Dissociation Kit of choice
- Plus 25 FREE gentleMACS™ C Tubes for tumor dissociation
- Plus 5% TRCCC contribution – 5% of the gentleMACS purchase price will be contributed by Miltenyi Biotec to sponsor the TRCCC meeting, February 20-23, 2013
Click here for more information.
American Cancer Society IRG Awards
The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
LOI Deadline: February 18
Application Deadline: April 5
Alex's Lemonade Stand Foundation Pediatric Oncology Student Training Program
Alex's Lemonade Stand Foundation (ALSF) is dedicated to funding pediatric oncology researchers at critical points in their careers. The Pediatric Oncology Student Training (POST) Program is designed for graduate and medical students who have an interest in pediatric oncology research and would like to experience the field first hand. Students train with a pediatric oncology research mentor. Students may join a research project underway in a mentor's lab or begin an original investigation with the mentor.
Deadline: March 4
MARK YOUR CALENDARS
Grant Writing Workshops
The CWRU Office of Research Administration is pleased to announce that Dr. Bob Lucas, Director of the Institute for Scholarly Productivity in San Luis Obispo, California, will be on campus to present two grant writing workshops:
Thursday, January 31
2-5:30 pm BRB 105
This workshop is intended for academics who are writing less than they would like. It assumes that many professors have done a great deal of publishable research –they just haven't written up the results.
Introduction to Proposal Writing
Friday, February 1
8 am - 12 pm WRB 1-413
This workshop introduces academics to the grants world. It gives beginners a framework for understanding this complex world and advice about how best to expend their energies to gain the maximum return from their efforts.
TRCCC Annual Meeting: The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity
Registration is open for the 16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC),The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity. Held February 20-22 at the Seven Springs Mountain Resort in Seven Springs, PA, this meeting will feature two symposiums focused on Tumor-mediated Immune Suppression and Vaccine and Cellular Therapy, with spotlight sessions on Imaging and Viral Vectors. The agenda will also include a poster session. Researchers, institutional officials, and students are invited to submit abstracts for poster presentations by February 4.
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Sarcoma Foundation of America
Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
NIH BULLETIN – Notices and Funding Opportunities
Notice of New Application Due Date with Temporary Increase in Budget Limit on AHRQ Large Research (R01) and Demonstration (R18) Grant Applications for Standing AHRQ Funding Opportunity Announcements (FOAs)(NOT-HS-13-005)
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.